What Crispr Therapeutics, Inc. pays on H-1B filings
Crispr Therapeutics, Inc. filed 21 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.
FY2026 so far · 12 LCAsFY2025 · 9 LCAs
Stated wages by title
| Title | LCAs | Year | Typical range | Median |
|---|---|---|---|---|
| Research Associate | 10 | FY2026 so far | $102,000 to $120,000 | $105,844 |
Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.
Filings by fiscal year
| Fiscal year | Certified LCAs |
|---|---|
| FY2026 (October to June) | 12 |
| FY2025 | 9 |
By prevailing-wage level
| Level | LCAs | Median stated wage |
|---|---|---|
| Level I (entry) | 2 | $809,931 |
| Level II (qualified) | 9 | $109,158 |
| Level III (experienced) | 7 | $138,000 |
| Level IV (fully competent) | 3 | $174,670 |
DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.
Top worksites
| Worksite | LCAs | Median stated wage |
|---|---|---|
| Boston, MA | 19 | $124,919 |
| South San Francisco, CA | 1 | $127,077 |
Looking at Crispr Therapeutics, Inc.?
Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.